Syenex
Operator of a mammalian synthetic biology company intended to harness the therapeutic potential of extracellular vesicles. The company discovers and commercializes targeted delivery vectors to acceler...
Valuation
$22M
Latest known
Share Price
N/A
Total Raised
$13.7M
Last Round
N/A